DMC-BH

11/18/2020 - "These results suggest that the DMC analogue DMC-BH has potent anti-tumor properties that warrant further study."
11/18/2020 - "DMC-BH exhibited potent anti-tumor activity in both the ectopic xenograft and PDTX models. "
01/01/2020 - "In addition, our results show that DMC-BH effectively crosses the blood-brain barrier to inhibit the growth of intracranial GSC tumors in vivo. "
11/18/2020 - "Indeed, bioluminescence measurements showed that DMC-BH exerted a significantly greater anti-tumor effect on orthotopic glioma growth than DMC. "
11/18/2020 - "We evaluated the anti-tumor effects of DMC-BH in an ectopic xenograft model, an orthotopic glioblastoma xenograft model and a patient-derived tumor xenograft (PDTX) model. "

11/18/2020 - "Western blotting showed that DMC-BH significantly decreased p-Akt and p-mTOR expression in orthotopic glioma tissues. "
11/18/2020 - "DMC-BH was cytotoxic against various glioma cells including SHG-44, C6, U251, U87, A172 and primary glioma cells. "
11/18/2020 - "Indeed, bioluminescence measurements showed that DMC-BH exerted a significantly greater anti-tumor effect on orthotopic glioma growth than DMC. "
01/01/2023 - "DMC-BH, a curcumin analog, has been reported to possess anticancer properties against human gliomas. "
01/01/2020 - "Demethoxycurcumin analogue DMC-BH inhibits orthotopic growth of glioma stem cells by targeting JNK/ERK signaling."

01/01/2023 - "Promising antitumor effects of the curcumin analog DMC-BH on colorectal cancer cells."

11/18/2020 - "We evaluated the anti-tumor effects of DMC-BH in an ectopic xenograft model, an orthotopic glioblastoma xenograft model and a patient-derived tumor xenograft (PDTX) model. "
11/18/2020 - "Demethoxycurcumin analogue DMC-BH exhibits potent anticancer effects on orthotopic glioblastomas."